NDC properties for NDC 9 51759-386
NDC item 51759038622
| NDC 9 | 51759-386 |
|---|---|
| NDC 10 | 51759-386-22 |
| NDC Item | 51759038622 |
| packaging | 2 KIT in 1 CARTON (51759-386-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE (51759-497-31) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-07-31 |
| Marketing status | active |
NDC item 51759049731
| NDC 9 | 51759-497 |
|---|---|
| NDC 10 | 51759-497-31 |
| NDC Item | 51759049731 |
| packaging | 0.2 mL in 1 SYRINGE |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |